Pharma The following chart shows the top 20 pharma companies in France, ranked by sales for the year 2015. Global giant Novartis leads the way, followed by national champion Sanofi, and American titan Pfizer. Click here to read more articles and interviews from France, and to download the latest free pharma…

Pharma The following chart shows the massive potential in the Dutch pharmaceuticals and healthcare markets; a population of almost 17 million with high per capita GDP where a large percentage of the population have long-term health conditions. Click here to read more articles and interviews from the Netherlands, and to download…

Romania Click here to read more articles and interviews from Romania, and to download the latest free pharma report from the country.

Romania Click here to read more articles and interviews from Romania, and to download the latest free pharma report from the country.

Romania Click here to read more articles and interviews from Romania, and to download the latest free pharma report from the country.

France France spends 11.6% of its GDP on health. This is behind the USA (17.1%) but ahead of Germany (11.2%), Japan (10.2%), Denmark (11.2%), and the united Kingdom (8.8%). The growth in healthcare spending as a share of GDP that occurred in 2009 across all of these countries can be attributed chiefly…

France

France The National Health Insurance Fund for employees (CNAMTS) is in charge of the health insurance branch of the Social Security system’s general scheme and manages the network of local health insurance funds (CPAM). 60 million general scheme beneficiaries. 91% of the population is insured by CNAMTS which covers 86% of…

France In France, the ACOSS (central agency of social security funds) is in charge of the social security general scheme’s cash operations. It manages the The Union of Social Security contribution and family benefit collection organizations which collect social contributions. In 2014 it • managed 9.6 million contributor accounts • collected 474.4…

The following graph shows the rise in pharmaceutical exports from Spain, which is now the fourth largest export sector in the country.

Spain Spain has seen a number of investments in recent months in the pharmaceutical sector: below is a non-comprehensive list of R&D, manufacturing, and clinical trials by international pharma companies.

Spain The following graph shows that the pharma is the leading sector when it comes to R&D in Spain, accounting for 20.2 percent of investment in 2013.